|Dr. Michael P. Goldsworthy B.Sc., BSc (Hons), FAIP, GAICD, M.Sc., MSc, Ph.D.||CEO, MD & Exec. Director||633.83k||N/A||1958|
|Ms. Julie E. Ducie B.Bus., C.A., CA, GAICD, M.B.A.||CFO & Company Sec.||387.71k||N/A||N/A|
|Dr. Geordie Graetz||Chief Commercial Officer||N/A||N/A||N/A|
Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser uranium enrichment technology in Australia. It operates through three segments: Silex Systems, Translucent, and Silex USA. The company also develops cREO, a semiconductor technology. Silex Systems Limited was incorporated in 1987 and is based in Sydney, Australia.
Silex Systems Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.